M&A Deal Summary

Fresenius Medical Care Acquires Renal Care Group

On May 4, 2005, Fresenius Medical Care acquired healthcare services company Renal Care Group for 3.5B USD

Acquisition Highlights
  • This is Fresenius Medical Care’s 1st transaction in the Healthcare Services sector.
  • This is Fresenius Medical Care’s largest (disclosed) transaction.
  • This is Fresenius Medical Care’s 2nd transaction in the United States.
  • This is Fresenius Medical Care’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2005-05-04
Target Renal Care Group
Sector Healthcare Services
Buyer(s) Fresenius Medical Care
Deal Type Add-on Acquisition
Deal Value 3.5B USD
Advisor(s) BofA Securities
Morgan Stanley (Financial)
Cravath, Swaine & Moore
Alston & Bird (Legal)

Target

Renal Care Group

Nashville, Tennessee, United States
Renal Care Group, Inc. is a specialized dialysis services company that provides care to patients with kidney disease. The Company serves over 30,400 patients at more than 425 owned outpatient dialysis facilities, in addition to providing acute dialysis services at more than 210 hospitals.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Fresenius Medical Care

Bad Homburg, Germany
Category Company
Founded 1996
Sector Healthcare Services
Employees117,128
Revenue 19.5B EUR (2023)
DESCRIPTION

Fresenius Medical Care a kidney dialysis company, provides renal dialysis products and services. Fresenius Medical Care was founded in 1996 and is based in Bad Homburg, Germany.

DEAL STATS #
Overall 3 of 16
Sector (Healthcare Services) 1 of 9
Type (Add-on Acquisition) 2 of 15
State (Tennessee) 1 of 2
Country (United States) 2 of 12
Year (2005) 2 of 2
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-04-21 Haemotec

Vaudreuil-Dorion, Quebec, Canada

Haemotec, Inc. is a manufacturer of hemodialysis concentrates.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-29 Renal Solutions

Warrendale, Pennsylvania, United States

Renal Solutions, Inc., a medical device and healthcare service company, is commercializing the Allient(R) Sorbent Hemodialysis System, a revolutionary technology/service solution for the chronic and acute dialysis market. The Allient System, brings SMARRT (Sorbent Management for Advanced Renal Replacement Therapy) therapy to the dialysis field, opening new treatment options to dialysis professionals and patients by virtue of its ability to provide short, standard or extended duration hemodialysis therapy using just 1 and 1/2 gallons of ordinary drinking water.

Buy $190M
Mergr

Product

Company

Legal